Sunmax Biotechnology Co., Ltd. (4728.TWO)
TWD 374.5
(-0.13%)
TWD 374.5
(-0.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 848.55 Million | 644.56 Million | 243.28 Million | 386.97 Million | - |
| Net Income | 909.39 Million | 777.17 Million | 357.48 Million | 337.75 Million | - |
| Depreciation & Amortization | 72.82 Million | 58.15 Million | 55.76 Million | 33.8 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 131.92 Million | 10.91 Million | -78.8 Million | 112.45 Million | - |
| Other non-cash items | -10.26 Million | -4.81 Million | -1.04 Million | -4.57 Million | - |
| Investing Cash Flow | -16.03 Million | -376.61 Million | -285.17 Million | -101.89 Million | - |
| Investments in PPE | -110.39 Million | -155.17 Million | -255.42 Million | -130.09 Million | - |
| Acquisitions | 419 Thousand | - | - | - | - |
| Investment purchases | -962 Thousand | -1.44 Million | -9.64 Million | -7.75 Million | - |
| Sales/Maturities of investments | 125 Million | -134.97 Million | 49.32 Million | 36.63 Million | - |
| Other Investing Activities | -30.1 Million | -86.55 Million | -72.96 Million | -2.25 Million | - |
| Financing Cash Flow | -549.79 Million | -281.2 Million | -131.96 Million | -95.38 Million | - |
| Debt repayment | -2.17 Million | - | - | - | -24 Million |
| Dividends payments | -517.39 Million | -239.63 Million | -108.92 Million | -81.69 Million | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -9.42 Million | -2.41 Million | 1.34 Million | 1.12 Million | - |
| Accounts receivables | -361 Thousand | - | - | - | - |
| Accounts payables | -7.61 Million | - | - | - | - |
| Inventory | -19.87 Million | -19.05 Million | -29.4 Million | 6.09 Million | - |
| Other working capital | 152.16 Million | - | - | - | - |
| Cash at beginning of period | 589.3 Million | 602.54 Million | 778.58 Million | 583.49 Million | - |
| Cash at end of period | 854.69 Million | 589.3 Million | 602.54 Million | 778.58 Million | - |
| Capital Expenditure | -110.39 Million | -155.17 Million | -255.42 Million | -130.09 Million | - |
| Effect of forex changes on cash | -17.32 Million | 8000.00 | -2.17 Million | 5.39 Million | - |
| Net cash flow / Change in cash | 265.39 Million | -13.24 Million | -176.03 Million | 195.08 Million | - |
| Free Cash Flow | 738.16 Million | 489.39 Million | -12.14 Million | 256.87 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 259.93 Million | 254.45 Million | 909.39 Million | 191.92 Million | 274.85 Million | 207.77 Million |
| Depreciation & Amortization | 24.78 Million | 24.01 Million | 72.82 Million | 20.83 Million | 18.59 Million | 16.35 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -84.34 Million | -93.07 Million | 131.92 Million | 41.12 Million | -11.74 Million | 86.5 Million |
| Other non-cash items | -1.7 Million | -1.64 Million | -10.26 Million | -6.67 Million | -466 Thousand | -2.08 Million |
| Investing Cash Flow | 32.36 Million | 60.65 Million | -16.03 Million | -24.2 Million | -100.69 Million | 132.36 Million |
| Investments in PPE | -10.13 Million | -11.22 Million | -110.39 Million | -50.38 Million | -20.09 Million | -10.78 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | 43.01 Million | 71.95 Million | - | -89.91 Million | -61.92 Million | 152.17 Million |
| Sales/Maturities of investments | - | - | 125 Million | 113.7 Million | -2000.00 | - |
| Other Investing Activities | -514 Thousand | -73 Thousand | -30.1 Million | 2.93 Million | -18.67 Million | -9.02 Million |
| Financing Cash Flow | -7.28 Million | -6.53 Million | -549.79 Million | -667 Thousand | -530.01 Million | -11.87 Million |
| Debt repayment | -7.39 Million | - | - | - | - | - |
| Dividends payments | - | - | -517.39 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 105 Thousand | 662 Thousand | -9.42 Million | -240 Thousand | -59 Thousand | -10.12 Million |
| Accounts receivables | 131 Thousand | - | - | - | - | - |
| Accounts payables | -2.32 Million | - | - | - | - | - |
| Inventory | -19.79 Million | -19.79 Million | -19.87 Million | -10.19 Million | 1.23 Million | -8.76 Million |
| Other working capital | -62.35 Million | - | - | - | - | - |
| Cash at beginning of period | 1.07 Billion | 854.69 Million | 589.3 Million | 666.67 Million | 1.09 Billion | 792.84 Million |
| Cash at end of period | 1.16 Billion | 1.07 Billion | 854.69 Million | 854.69 Million | 666.67 Million | 1.09 Billion |
| Capital Expenditure | -10.13 Million | -11.22 Million | -110.39 Million | -50.38 Million | -20.09 Million | -10.78 Million |
| Effect of forex changes on cash | 792 Thousand | 6.35 Million | -17.32 Million | -15.68 Million | 8.74 Million | -8.94 Million |
| Net cash flow / Change in cash | 89.16 Million | 220.03 Million | 265.39 Million | 188.02 Million | -427.22 Million | 301.04 Million |
| Free Cash Flow | 53.16 Million | 148.32 Million | 738.16 Million | 178.19 Million | 174.65 Million | 178.7 Million |
3545
NXGT
ADTN
LHSC
4920
VTSCF